傳陸金所美國IPO以上限13.5美元定價 籌資24億美元
據《彭博》引述消息人士報道,中國平安(02318.HK)旗下陸金所在美國的IPO將以每份存託股份13.5美元定價,為招股價範圍11.5至13.5美元的上限。是次招股將發行1.75億份美國存託股份(ADS),料籌資24億美元,集資規模令陸金所成為中資公司今年在美國的最大IPO之一。
按13.50美元定價計算,而兩份ADS相當於一股陸金所普通股,陸金所的估值約330億美元,公司募集資金用途料包括產品開發、銷售和營銷活動,技術基礎設施,收購或投資。高盛、美銀、瑞銀、匯控及平安證券為是次招股安排行。股份預計今日(30日)在紐約證交所開始交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.